The FDA has accepted for review the New Drug Application for SYD-101 (atropine sulfate) to slow the progression of myopia in children.
The survey included a national sample of 999 physicians. It found that 86% of respondents, even those who do not work ...
Although current federal budget considerations create much uncertainty concerning future Medicaid funding and program changes ...